Even Moderate Exercise Linked to Reduced Mortality After Breast Cancer

THURSDAY, Nov. 17, 2022 (HealthDay News) -- Even moderate physical activity is associated with a reduced risk for mortality for breast cancer survivors, according to a study published online Nov. 17 in JAMA Network Open.
Lie Hong Chen, Dr.P.H., from Kaiser Permanente Southern California in Pasadena, and colleagues conducted a cohort study of 315 postmenopausal breast cancer survivors who received their initial diagnosis at least two years earlier. Participants were initially diagnosed with early-stage breast cancer between 1996 and 2012. Using two validated questionnaires, participants were queried about leisure-time physical activity and fatigue.
The researchers found that 45 participants (14.3 percent) died due to any cause during a median follow-up of 8.7 years after baseline, including five who died due to breast cancer. The mortality rates were 12.9, 13.4, and 32.9 per 1,000 person-years for active, moderately active, and insufficiently active participants, respectively. Those who were active or moderately active had a significantly reduced risk for death compared with insufficiently active participants in a multivariable analysis (hazard ratio, 0.42 and 0.40, respectively).
"Our findings further suggest that survivorship care plans should consider incorporating physical activity because even moderate activity may be vital for extending survival as well as health-related quality of life," the authors write. "Our findings have implications for patient counseling on the benefits of exercise with regard to cancer outcomes, and this protection persists even after considering cancer treatments in the analysis."
Related Posts
Menthols Make Up 40% of U.S. Cigarette Sales; Ban Could Have Huge Impact
FRIDAY, Oct. 14, 2022 (HealthDay News) -- A proposed ban on menthol cigarettes...
Health Highlights: April 22, 2022
Public health experts weigh in on the CDC's new forecasting service for...
Experimental Alzheimer’s Drug Slows Decline in Thinking in Late-Stage Trial
WEDNESDAY, May 3, 2023 (HealthDay News) -- Another experimental drug meant for...
Many Women May Overestimate Risks From Genes Tied to Breast Cancer
TUESDAY, Sept. 19, 2023 (HealthDay News) -- Women who carry mutations in genes...